Global Prosthetic Heart Valve & Artificial Heart Valve Market Research Report 2022

Publisher Name :
Date: 11-Jul-2022
No. of pages: 115
Inquire Before Buying

Due to the COVID-19 pandemic, the global Prosthetic Heart Valve & Artificial Heart Valve market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Prosthetic Heart Valve & Artificial Heart Valve market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Prosthetic Heart Valve & Artificial Heart Valve landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Transcatheter Heart Valve accounting for % of the Prosthetic Heart Valve & Artificial Heart Valve global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Rheumatic Heart Disease segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Prosthetic Heart Valve & Artificial Heart Valve include Edwards Lifesciences Corporation, Medtronic Plc, St. Jude Medical Inc.(Abbott Laboratories Company), Boston Scientific Corporation, Livanova Plc, Symetis, Jenavalve Technology Inc., Cryolife Inc. and Ttk Healthcare Limited, etc. In terms of revenue, the global 3 largest players have a % market share of Prosthetic Heart Valve & Artificial Heart Valve in 2021.

This report focuses on Prosthetic Heart Valve & Artificial Heart Valve volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Prosthetic Heart Valve & Artificial Heart Valve market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Prosthetic Heart Valve & Artificial Heart Valve Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Transcatheter Heart Valve

- Tissue Heart Valve

- Mechanical Heart Valve

Segment by Application

- Rheumatic Heart Disease

- Congenital Heart Disease

- Marfan Syndrome

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Edwards Lifesciences Corporation

- Medtronic Plc

- St. Jude Medical Inc.(Abbott Laboratories Company)

- Boston Scientific Corporation

- Livanova Plc

- Symetis

- Jenavalve Technology Inc.

- Cryolife Inc.

- Ttk Healthcare Limited

- Colibri Heart Valve

- Lepu Medical Technology

- Braile Biomédica

- Micro Interventional Devices

- Autotissue Berlin Gmbh

- Comed B.V.

- Meril Life Sciences

- Labcor Laboratório

- HLT Inc.(A Bracco Group Company)

- Medtronic

- Edwards Lifesciences Corporation

- Boston Scientific Corporation

- Livanova Plc

- St. Jude Medical, Inc.(An Abbott Laboratories Company)

- Symetis Sa

- Jenavalve Technology, Inc.

- Cryolife, Inc.

- TTK Healthcare Limited(A Ttk Group Company)

- Colibri Heart Valve, Llc

- Lepu Medical Technology Co., Ltd.

- Braile Biomédica

Global Prosthetic Heart Valve & Artificial Heart Valve Market Research Report 2022

Table of Contents
1 Prosthetic Heart Valve & Artificial Heart Valve Market Overview
1.1 Product Overview and Scope of Prosthetic Heart Valve & Artificial Heart Valve
1.2 Prosthetic Heart Valve & Artificial Heart Valve Segment by Type
1.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Transcatheter Heart Valve
1.2.3 Tissue Heart Valve
1.2.4 Mechanical Heart Valve
1.3 Prosthetic Heart Valve & Artificial Heart Valve Segment by Application
1.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Comparison by Application: (2022-2028)
1.3.2 Rheumatic Heart Disease
1.3.3 Congenital Heart Disease
1.3.4 Marfan Syndrome
1.3.5 Other
1.4 Global Prosthetic Heart Valve & Artificial Heart Valve Market Size Estimates and Forecasts
1.4.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue 2017-2028
1.4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales 2017-2028
1.4.3 Prosthetic Heart Valve & Artificial Heart Valve Market Size by Region: 2017 Versus 2021 Versus 2028
2 Prosthetic Heart Valve & Artificial Heart Valve Market Competition by Manufacturers
2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Manufacturers (2017-2022)
2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Prosthetic Heart Valve & Artificial Heart Valve Manufacturing Sites, Area Served, Product Type
2.5 Prosthetic Heart Valve & Artificial Heart Valve Market Competitive Situation and Trends
2.5.1 Prosthetic Heart Valve & Artificial Heart Valve Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prosthetic Heart Valve & Artificial Heart Valve Players Market Share by Revenue
2.5.3 Global Prosthetic Heart Valve & Artificial Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prosthetic Heart Valve & Artificial Heart Valve Retrospective Market Scenario by Region
3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.3.1 North America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country
3.3.2 North America Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.4.1 Europe Prosthetic Heart Valve & Artificial Heart Valve Sales by Country
3.4.2 Europe Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Region
3.5.1 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales by Region
3.5.2 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.6.1 Latin America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country
3.6.2 Latin America Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.7.1 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Sales by Country
3.7.2 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prosthetic Heart Valve & Artificial Heart Valve Historic Market Analysis by Type
4.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Type (2017-2022)
4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Type (2017-2022)
4.3 Global Prosthetic Heart Valve & Artificial Heart Valve Price by Type (2017-2022)
5 Global Prosthetic Heart Valve & Artificial Heart Valve Historic Market Analysis by Application
5.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Application (2017-2022)
5.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Application (2017-2022)
5.3 Global Prosthetic Heart Valve & Artificial Heart Valve Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Edwards Lifesciences Corporation
6.1.1 Edwards Lifesciences Corporation Corporation Information
6.1.2 Edwards Lifesciences Corporation Description and Business Overview
6.1.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.1.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.2 Medtronic Plc
6.2.1 Medtronic Plc Corporation Information
6.2.2 Medtronic Plc Description and Business Overview
6.2.3 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.2.5 Medtronic Plc Recent Developments/Updates
6.3 St. Jude Medical Inc.(Abbott Laboratories Company)
6.3.1 St. Jude Medical Inc.(Abbott Laboratories Company) Corporation Information
6.3.2 St. Jude Medical Inc.(Abbott Laboratories Company) Description and Business Overview
6.3.3 St. Jude Medical Inc.(Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.3.4 St. Jude Medical Inc.(Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.3.5 St. Jude Medical Inc.(Abbott Laboratories Company) Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Corporation Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 Livanova Plc
6.5.1 Livanova Plc Corporation Information
6.5.2 Livanova Plc Description and Business Overview
6.5.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.5.5 Livanova Plc Recent Developments/Updates
6.6 Symetis
6.6.1 Symetis Corporation Information
6.6.2 Symetis Description and Business Overview
6.6.3 Symetis Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Symetis Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.6.5 Symetis Recent Developments/Updates
6.7 Jenavalve Technology Inc.
6.6.1 Jenavalve Technology Inc. Corporation Information
6.6.2 Jenavalve Technology Inc. Description and Business Overview
6.6.3 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.7.5 Jenavalve Technology Inc. Recent Developments/Updates
6.8 Cryolife Inc.
6.8.1 Cryolife Inc. Corporation Information
6.8.2 Cryolife Inc. Description and Business Overview
6.8.3 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.8.5 Cryolife Inc. Recent Developments/Updates
6.9 Ttk Healthcare Limited
6.9.1 Ttk Healthcare Limited Corporation Information
6.9.2 Ttk Healthcare Limited Description and Business Overview
6.9.3 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.9.5 Ttk Healthcare Limited Recent Developments/Updates
6.10 Colibri Heart Valve
6.10.1 Colibri Heart Valve Corporation Information
6.10.2 Colibri Heart Valve Description and Business Overview
6.10.3 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.10.5 Colibri Heart Valve Recent Developments/Updates
6.11 Lepu Medical Technology
6.11.1 Lepu Medical Technology Corporation Information
6.11.2 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.11.3 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.11.5 Lepu Medical Technology Recent Developments/Updates
6.12 Braile Biomédica
6.12.1 Braile Biomédica Corporation Information
6.12.2 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.12.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.12.5 Braile Biomédica Recent Developments/Updates
6.13 Micro Interventional Devices
6.13.1 Micro Interventional Devices Corporation Information
6.13.2 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.13.3 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.13.5 Micro Interventional Devices Recent Developments/Updates
6.14 Autotissue Berlin Gmbh
6.14.1 Autotissue Berlin Gmbh Corporation Information
6.14.2 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.14.3 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.14.5 Autotissue Berlin Gmbh Recent Developments/Updates
6.15 Comed B.V.
6.15.1 Comed B.V. Corporation Information
6.15.2 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.15.3 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.15.5 Comed B.V. Recent Developments/Updates
6.16 Meril Life Sciences
6.16.1 Meril Life Sciences Corporation Information
6.16.2 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.16.3 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.16.5 Meril Life Sciences Recent Developments/Updates
6.17 Labcor Laboratório
6.17.1 Labcor Laboratório Corporation Information
6.17.2 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.17.3 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.17.5 Labcor Laboratório Recent Developments/Updates
6.18 HLT Inc.(A Bracco Group Company)
6.18.1 HLT Inc.(A Bracco Group Company) Corporation Information
6.18.2 HLT Inc.(A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.18.3 HLT Inc.(A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.18.4 HLT Inc.(A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.18.5 HLT Inc.(A Bracco Group Company) Recent Developments/Updates
6.19 Medtronic
6.19.1 Medtronic Corporation Information
6.19.2 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.19.3 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.19.5 Medtronic Recent Developments/Updates
6.20 Edwards Lifesciences Corporation
6.20.1 Edwards Lifesciences Corporation Corporation Information
6.20.2 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.20.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.20.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.21 Boston Scientific Corporation
6.21.1 Boston Scientific Corporation Corporation Information
6.21.2 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.21.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.21.5 Boston Scientific Corporation Recent Developments/Updates
6.22 Livanova Plc
6.22.1 Livanova Plc Corporation Information
6.22.2 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.22.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.22.5 Livanova Plc Recent Developments/Updates
6.23 St. Jude Medical, Inc.(An Abbott Laboratories Company)
6.23.1 St. Jude Medical, Inc.(An Abbott Laboratories Company) Corporation Information
6.23.2 St. Jude Medical, Inc.(An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.23.3 St. Jude Medical, Inc.(An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.23.4 St. Jude Medical, Inc.(An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.23.5 St. Jude Medical, Inc.(An Abbott Laboratories Company) Recent Developments/Updates
6.24 Symetis Sa
6.24.1 Symetis Sa Corporation Information
6.24.2 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.24.3 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.24.5 Symetis Sa Recent Developments/Updates
6.25 Jenavalve Technology, Inc.
6.25.1 Jenavalve Technology, Inc. Corporation Information
6.25.2 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.25.3 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.25.5 Jenavalve Technology, Inc. Recent Developments/Updates
6.26 Cryolife, Inc.
6.26.1 Cryolife, Inc. Corporation Information
6.26.2 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.26.3 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.26.5 Cryolife, Inc. Recent Developments/Updates
6.27 TTK Healthcare Limited(A Ttk Group Company)
6.27.1 TTK Healthcare Limited(A Ttk Group Company) Corporation Information
6.27.2 TTK Healthcare Limited(A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.27.3 TTK Healthcare Limited(A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.27.4 TTK Healthcare Limited(A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.27.5 TTK Healthcare Limited(A Ttk Group Company) Recent Developments/Updates
6.28 Colibri Heart Valve, Llc
6.28.1 Colibri Heart Valve, Llc Corporation Information
6.28.2 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.28.3 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.28.5 Colibri Heart Valve, Llc Recent Developments/Updates
6.29 Lepu Medical Technology Co., Ltd.
6.29.1 Lepu Medical Technology Co., Ltd. Corporation Information
6.29.2 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.29.3 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.29.4 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.29.5 Lepu Medical Technology Co., Ltd. Recent Developments/Updates
6.30 Braile Biomédica
6.30.1 Braile Biomédica Corporation Information
6.30.2 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.30.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2022)
6.30.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.30.5 Braile Biomédica Recent Developments/Updates
7 Prosthetic Heart Valve & Artificial Heart Valve Manufacturing Cost Analysis
7.1 Prosthetic Heart Valve & Artificial Heart Valve Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prosthetic Heart Valve & Artificial Heart Valve
7.4 Prosthetic Heart Valve & Artificial Heart Valve Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prosthetic Heart Valve & Artificial Heart Valve Distributors List
8.3 Prosthetic Heart Valve & Artificial Heart Valve Customers
9 Prosthetic Heart Valve & Artificial Heart Valve Market Dynamics
9.1 Prosthetic Heart Valve & Artificial Heart Valve Industry Trends
9.2 Prosthetic Heart Valve & Artificial Heart Valve Market Drivers
9.3 Prosthetic Heart Valve & Artificial Heart Valve Market Challenges
9.4 Prosthetic Heart Valve & Artificial Heart Valve Market Restraints
10 Global Market Forecast
10.1 Prosthetic Heart Valve & Artificial Heart Valve Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prosthetic Heart Valve & Artificial Heart Valve by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Prosthetic Heart Valve & Artificial Heart Valve by Type (2023-2028)
10.2 Prosthetic Heart Valve & Artificial Heart Valve Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prosthetic Heart Valve & Artificial Heart Valve by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Prosthetic Heart Valve & Artificial Heart Valve by Application (2023-2028)
10.3 Prosthetic Heart Valve & Artificial Heart Valve Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prosthetic Heart Valve & Artificial Heart Valve by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Prosthetic Heart Valve & Artificial Heart Valve by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Prosthetic Heart Valve & Artificial Heart Valve Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Prosthetic Heart Valve & Artificial Heart Valve Market Competitive Situation by Manufacturers in 2021
Table 5. Global Prosthetic Heart Valve & Artificial Heart Valve Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Prosthetic Heart Valve & Artificial Heart Valve Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Prosthetic Heart Valve & Artificial Heart Valve Manufacturing Sites and Area Served
Table 11. Manufacturers Prosthetic Heart Valve & Artificial Heart Valve Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prosthetic Heart Valve & Artificial Heart Valve by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prosthetic Heart Valve & Artificial Heart Valve as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2017-2022) & (Units)
Table 16. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Region (2017-2022)
Table 17. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Region (2017-2022)
Table 19. North America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2022) & (Units)
Table 20. North America Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Country (2017-2022)
Table 21. North America Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Country (2017-2022)
Table 23. Europe Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2022) & (Units)
Table 24. Europe Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Country (2017-2022)
Table 25. Europe Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Region (2017-2022)
Table 31. Latin America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2022) & (Units)
Table 32. Latin America Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Country (2017-2022)
Table 33. Latin America Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Country (2017-2022)
Table 39. Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type (2017-2022) & (Units)
Table 40. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Type (2017-2022)
Table 41. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Type (2017-2022)
Table 43. Global Prosthetic Heart Valve & Artificial Heart Valve Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Prosthetic Heart Valve & Artificial Heart Valve Sales (Units) by Application (2017-2022)
Table 45. Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Application (2017-2022)
Table 46. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Share by Application (2017-2022)
Table 48. Global Prosthetic Heart Valve & Artificial Heart Valve Price by Application (2017-2022) & (USD/Unit)
Table 49. Edwards Lifesciences Corporation Corporation Information
Table 50. Edwards Lifesciences Corporation Description and Business Overview
Table 51. Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product
Table 53. Edwards Lifesciences Corporation Recent Developments/Updates
Table 54. Medtronic Plc Corporation Information
Table 55. Medtronic Plc Description and Business Overview
Table 56. Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Product
Table 58. Medtronic Plc Recent Developments/Updates
Table 59. St. Jude Medical Inc.(Abbott Laboratories Company) Corporation Information
Table 60. St. Jude Medical Inc.(Abbott Laboratories Company) Description and Business Overview
Table 61. St. Jude Medical Inc.(Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. St. Jude Medical Inc.(Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product
Table 63. St. Jude Medical Inc.(Abbott Laboratories Company) Recent Developments/Updates
Table 64. Boston Scientific Corporation Corporation Information
Table 65. Boston Scientific Corporation Description and Business Overview
Table 66. Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product
Table 68. Boston Scientific Corporation Recent Developments/Updates
Table 69. Livanova Plc Corporation Information
Table 70. Livanova Plc Description and Business Overview
Table 71. Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product
Table 73. Livanova Plc Recent Developments/Updates
Table 74. Symetis Corporation Information
Table 75. Symetis Description and Business Overview
Table 76. Symetis Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Symetis Prosthetic Heart Valve & Artificial Heart Valve Product
Table 78. Symetis Recent Developments/Updates
Table 79. Jenavalve Technology Inc. Corporation Information
Table 80. Jenavalve Technology Inc. Description and Business Overview
Table 81. Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Product
Table 83. Jenavalve Technology Inc. Recent Developments/Updates
Table 84. Cryolife Inc. Corporation Information
Table 85. Cryolife Inc. Description and Business Overview
Table 86. Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Product
Table 88. Cryolife Inc. Recent Developments/Updates
Table 89. Ttk Healthcare Limited Corporation Information
Table 90. Ttk Healthcare Limited Description and Business Overview
Table 91. Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs